Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma-Reference-Cited by-同舟云学术

Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma

Published:2010-11 Issue: Volume:36 Page:S21-S29
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Bronte Giuseppe,Rizzo Sergio,La Paglia Laura,Adamo Vincenzo,Siragusa Sergio,Ficorella Corrado,Santini Daniele,Bazan Viviana,Colucci Giuseppe,Gebbia Nicola,Russo Antonio

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference87 articles.

1. EGFR antagonists in cancer treatment;Ciardiello;N Engl J Med,2008

2. Epidermal growth factor receptor mutations in lung cancer;Sharma;Nat Rev,2007

3. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected];Fukuoka;J Clin Oncol,2003

4. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial;Kris;JAMA,2003

5. Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer;Perez-Soler;J Clin Oncol,2004

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Weighted gene co-expression network analysis and whole genome sequencing identify potential lung cancer biomarkers;Frontiers in Oncology;2024-05-24

2. Deciphering disulfidptosis: Uncovering a lncRNA-based signature for prognostic assessment, personalized immunotherapy, and therapeutic agent selection in lung adenocarcinoma patients;Cellular Signalling;2024-05

3. Oncogenic Driver Mutations in Nonsmall Cell Lung Cancer;Pulmon;2024-05

4. Development of m6A/m5C/m1A regulated lncRNA signature for prognostic prediction, personalized immune intervention and drug selection in LUAD;Journal of Cellular and Molecular Medicine;2024-04

5. Graphene oxide-based biosensors for detection of lung cancer: A review;Results in Chemistry;2024-01